Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Sep;10(9):OD05-OD06.
doi: 10.7860/JCDR/2016/22215.8483. Epub 2016 Sep 1.

Unexplained Persistent Hyperglycaemia in a Type I Diabetes Patient - Is Injection Site Lipohypertrophy the Cause?

Ranjana Ajit Sahasrabudhe  1 , Tejas Yashwant Limaye  2 , Vidya Sanjay Gokhale  3
Affiliations
Case Reports

Unexplained Persistent Hyperglycaemia in a Type I Diabetes Patient - Is Injection Site Lipohypertrophy the Cause?

Ranjana Ajit Sahasrabudhe et al. J Clin Diagn Res. 2016 Sep.

Abstract

Type I diabetes patients depend on insulin injections. Proper injection technique is essential for good glycaemic control. Incorrect technique can also lead to local injection site adverse effects, commonest being lipohypertrophy. Hypoglycaemia, by far the most dreaded adverse effect of insulin, receives utmost focus in management of patients on insulin. Lipohypertrophy, on the other hand, is a relatively neglected adverse effect. It is necessary for health care providers to realize that it can also have serious clinical implications. We present a case of persistent unexplained hyperglycaemia in a Type I Diabetes Mellitus (TIDM) patient with severe injection site lipohypertropy. After switching to normal unused sites, her blood sugar levels improved, along with reduction in insulin requirement. The case highlights the importance of continuous patient education and alert monitoring by health care providers.

Keywords: Insulin injection technique; Patient education; Site rotation.

PubMed Disclaimer

Figures

[Table/Fig-1a,b]:
[Table/Fig-1a,b]:
Injection sites showing lipohypertrophy on antero-medial aspect of thighs a: Massive lipohypertrophy at visit 1 b: Reduced lipohypertrophy six months after discontinuing the use of this site.
See this image and copyright information in PMC

References

    1. Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, et al. Impaired absorption of insulin as part from lipohypertrophic injection sites. Diabetes Care. 2005;28(8):2025–27. - PubMed
    1. Heinemann L. Insulin absorption from lipodystrophic areas: A (neglected) source of trouble for insulin therapy? J Diabetes Sci Technol. 2010;4(3):750–53. - PMC - PubMed
    1. Shrivastava SR, Shrivastav PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord. 2013;12:14. - PMC - PubMed
    1. Forum for Injection technique FIT ODC International available from: http://www.fit4diabetes.com/ accessed on 8th March 2016.
    1. Nikhil Tandon, Sanjay Kalra, Balhara Yatan Pal Singh, Baruah Manash P., Chadha Manoj, Chandalia Hemraj B, et al. Forum for Injection technique (FIT), India: The Indian recommendations 2.0, for best practice in insulin injection technique, 2015. Indian. J Endocrinol Metab. 2015;19(3):317–31. - PMC - PubMed

Publication types